Colorectal neoplasmsNeoplasms metastasisLiverAngiogenesis factorSignificant advances have been made in the treatment of advanced colorectal cancer over the past 5 years, namely due to the introduction of three novel cytotoxic agents-capecitabine (Xeloda), irinotecan (Camptosar), and oxaliplatin (Eloxatin)...
Cuyle PJ, Prenen H (2017) Current and future biomarkers in the treatment of colorectal cancer. Acta Clin Belg 72: 103-15.P. J. Cuyle and H. Prenen, "Current and future biomarkers in the treatment of colorectal cancer," Acta Clinica Belgica, vol. 72, no. 2, pp. 103-115, 2016....
Liver-Directed Treatments for Metastatic Colorectal Cancer When possible, surgical resection remains the "gold standard" for the treatment of hepatic colorectal metastases. Liver resection should be considered when... Choti,A Michael - 《Current Treatment Options in Oncology》 被引量: 12发表: 2014年...
Current treatment for liver metastases from colorectal cancer. The liver is the commonest site of distant metastasis of colorectal cancer and nearly half of the patients with colorectal cancer ultimately develop liver ... Lian-Xin,Liu,Wei-Hui,... - 《World Journal of Gastroenterology》 被引量:...
Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patientsdoi:10.2147/OTT.S3651metastaticcolorectalcancercetuximabelderlypatientsPerPfeifferCarmillaQvortrupJonKBjerregaardDove PressOncotargets & Therapy...
Current Treatment Strategies in Elderly Patients with Metastatic Colorectal Cancerdoi:10.3816/CCC.2007.n.016Chemotherapy5-FluorouracilIrinotecanLeucovorinOxaliplatinColorectal cancer (CRC) is one of the most common cancers in the Western world, with > 500,000 new cases diagnosed each year. One of the ...
When it comes to peritoneal dissemination of colorectal cancer, the story is quite different. It affects approximately 15,000 new patients per year, and traditionally, it has been labeled as a terminal condition for which there is no reasonable treatment option even though an uncontested statement ...
Treatment strategies for metastatic colorectal cancer (mCRC) patients have undergone dramatic changes in the past decade and despite improved patient outcomes, there still exist areas for continued development. The introduction of targeted agents has provided clinicians with additional treatment options in ...
of the homologous recombination repair in colorectal cancer—a case control study Polymorphisms In Rad,Renata Krupa,Tomasz Sliwinski,... 被引量: 30发表: 2013年 Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives Gastric cancer (GC) is the second leading ca...
According toresearchled by Prof. Varut Lohsiriwat, Professor of Surgery, Division of General Surgery (Section of Colorectal Surgery) of Siriraj Hospital, at Mahidol University, colorectal cancer (CRC) is the third most common cancer in Thailand, accounting for 11% of the cancer burden. It is ...